Summary
- Current Price
- As of today, CRDF price is $1.05, up +1.94% on
- Current Price All-Time High
- CRDF price is currently -99.95% below its historical high of $2,030.40 set on
- Market Cap
- CRDF current market cap is $82M, down -47.30% year-over-year
- Revenue
- CRDF current annual revenue is $593.00K, down -13.18% year-over-year
- Next Earnings
- The next earnings release for CRDF is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cardiff Oncology, Inc. |
| Ticker | NASDAQ: CRDF |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cardiffoncology.com |
| Employees | 32 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.05 | ||
| Price, 1D Change | +1.94% | |
| $82M | ||
| - | ||
| - | ||
| 2.21 | ||
| $593.00K | ||
| Revenue, 1Y Change | -13.18% | |
| -$0.69 | ||
| EPS, 1Y Change | +28.04% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:6 | |
| Next Split | N/A | N/A |
| Last Ticker Change | TROV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.69 | ||
| EPS Estimate | -$0.69 | N/A |
| EPS Est. Change | -0.04% | N/A |
| $593.00K | ||
| Revenue Estimate | $229.56K | N/A |
| Revenue Est. Change | -61.29% | N/A |
| $1.05 | ||
| Price Target | $4.00 | - |
| Price Tgt. Change | +280.95% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.99 | -$0.95 | +3.40% | |
| -$0.78 | -$0.69 | +11.63% | |
| -$0.69 | N/A | -0.04% | |
| -$0.81 | N/A | -18.59% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $610.67K | $683.00K | +11.84% | |
| $452.00K | $593.00K | +31.19% | |
| $229.56K | N/A | -61.29% | |
| $189.29K | N/A | -68.08% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -54.94% | ||
| -46.97% | ||
| -47.30% | ||
| -7.66% | ||
| -13.18% | ||
| +53.63% | ||
| +28.04% | ||
| +22.73% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.05 | ||
| $1.83 | ||
| $1.17 | ||
| $1.75 | ||
| $1.16 | ||
| -$0.05 | ||
| 2.21 | ||
| $0.08 | ||
| 53.17 | ||
| 44.10% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $593.00K | ||
| -$0.69 | ||
| -$311.00K | ||
| -52.45% | ||
| -$48.96M | ||
| -8,256.32% | ||
| -$45.85M | ||
| -7,732.04% | ||
| -$48.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 3.67 | ||
| 3.67 | ||
| - | ||
| 2 | ||
| -8.51 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 155.59 | ||
| 2.35 | ||
| -0.78 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $45.39M | ||
| $58.30M | ||
| $61.88M | ||
| $60.13M | ||
| $16.50M | ||
| $16.39M | ||
| $832.00K | ||
| $730.00K | ||
| $8.09M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $46.44M | ||
| $48.65M | ||
| $904.00K | ||
| $0.00 | ||
| $904.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$37.92M | ||
| $1.34M | ||
| $2.58M | ||
| $44.00K | ||
| -$37.97M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Craig-Hallum | → | |
| TD Cowen | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Ladenburg Thalmann | ||
| Jefferies | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with CRDF
FAQ
- What is the ticker symbol for Cardiff Oncology, Inc.?
- The ticker symbol for Cardiff Oncology, Inc. is NASDAQ:CRDF
- Does Cardiff Oncology, Inc. pay dividends?
- No, Cardiff Oncology, Inc. does not pay dividends
- What sector is Cardiff Oncology, Inc. in?
- Cardiff Oncology, Inc. is in the Healthcare sector
- What industry is Cardiff Oncology, Inc. in?
- Cardiff Oncology, Inc. is in the Biotechnology industry
- What country is Cardiff Oncology, Inc. based in?
- Cardiff Oncology, Inc. is headquartered in United States
- When did Cardiff Oncology, Inc. go public?
- Cardiff Oncology, Inc. initial public offering (IPO) was on July 27, 2004
- Is Cardiff Oncology, Inc. in the S&P 500?
- No, Cardiff Oncology, Inc. is not included in the S&P 500 index
- Is Cardiff Oncology, Inc. in the NASDAQ 100?
- No, Cardiff Oncology, Inc. is not included in the NASDAQ 100 index
- Is Cardiff Oncology, Inc. in the Dow Jones?
- No, Cardiff Oncology, Inc. is not included in the Dow Jones index
- When was Cardiff Oncology, Inc. last earnings report?
- Cardiff Oncology, Inc.'s most recent earnings report was on May 14, 2026
- When does Cardiff Oncology, Inc. report earnings?
- The next expected earnings date for Cardiff Oncology, Inc. is August 11, 2026
Data Sources & References
- CRDF Official Website www.cardiffoncology.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1213037/000119312526067464/0001193125-26-067464-index.htm
- CRDF Profile on Yahoo Finance finance.yahoo.com/quote/CRDF
- CRDF Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crdf